In contrast, however, it has been demonstrated that MCs can also affect the antitumor immunity via activation of various types of immune cells such as NK cells, dendritic cells (DCs), cytotoxic T (CD8+) cells, and T-helper (CD4+) cells at tumor sites [53]. Here, CD8A is linked to neoplasm.